20 May 2010
Lateral rectus muscle as a new reference point in estimation of Graves’ ophthalmopathy activity
Agata Majos, Michał Pająk, Marcin Elgalal, Marek Olszycki, Ludomir StefańczykMed Sci Monit 2010; 16(1): 80-85 :: ID: 880588
Abstract
Background: The clinical progression of Grave’s ophthalmopathy (GO) is evaluated based on different parameters. Still, there is greater opportunity to carry out morphometric measurements, than to perform a quasi patho-physiological assessment.
The aims of this study were to evaluate the correlation of T2 relaxation time to muscle volume based on MR imaging and to investigate whether individual physical relativization of extraocular muscle volume significantly influences results.
Material/Methods: Ten controls and 20 patients underwent MR examination. Quantitative muscle assessment was carried out using a numerical segmentation image technique. T2 relaxation times were measured for each muscle, and a standardization algorithm was applied based on T2 relaxation time of ipsilateral frontal lobe white matter.
For each extraocular muscle, an absolute volume and a relative value were calculated by subtracting from each of these muscles’s volume from the volume of the lateral rectus muscle (RM) within the same orbital cavity.
Results: Highest correlation for relative T2 relaxation time and muscle volume was observed for inferior RM (value of r=0.520, which increased to r=0.660 after relativization). An increase in correlation for medial RM was also noted from r=0.473 to r=0.48. However, this correlation decreased slightly for superior RM from a value of r=0.597 to r=0.525.
Conclusions: Oculomotor muscle volume closely correlates to T2 relaxation time. Individual physical objectification significantly increases this correlation for MRM and IRM and consequently enables more precise use of muscle volume as an indicator of GO. Relativization is essential for data from both magnetic resonance and computer tomography studies.
Keywords: Graves’ ophthalmopathy, volume assessment, computer applications
Editorial
01 June 2025 : Editorial
Editorial: Harmonization and Publication of the 2025 Updates of the CONSORT and SPIRIT Statements for Clinical TrialsDOI: 10.12659/MSM.949923
Med Sci Monit 2025; 31:e949923
In Press
Clinical Research
Biomarker Discovery in Childhood Asthma: A Pilot Study of Serum Metabolite Analysis for IgE-Dependent AllergyMed Sci Monit In Press; DOI: 10.12659/MSM.948478
Review article
Antitumor Alkaloids in Tibetan Corydalis: Chemical Diversity and Pharmacological InsightsMed Sci Monit In Press; DOI: 10.12659/MSM.947268
Clinical Research
Differentiating Between Methylphenidate Use and Misuse: Clinical Insights From University Students and Acad...Med Sci Monit In Press; DOI: 10.12659/MSM.948984
Clinical Research
Six-Year Outcomes of CABG vs PCI in Diabetic Patients with Multivessel Coronary DiseaseMed Sci Monit In Press; DOI: 10.12659/MSM.948348
Most Viewed Current Articles
17 Jan 2024 : Review article 9,080,994
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,112
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 32,983
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 27,378
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912